Effectiveness of using tranexamic acid in total hip and total knee arthroplasty

References

1. 1.↵
   1. Smilowitz NR,
   2. Oberweis BS,
   3. Nukala S,
   4. Rosenberg A,
   5. Zhao S,
   6. Xu J, et al.

   Association between anemia, bleeding, and transfusion with long-term mortality following noncardiac surgery. Am J Med 2016; 129: 315–323.

   OpenUrl
2. 2.↵
   1. Ng W,
   2. Jerath A,
   3. Wąsowicz M.

   Tranexamic acid: a clinical review. Anaesthesiol Intensive Ther 2015; 47: 339–350.

   OpenUrlCrossRef
3. 3.↵
   1. Moskal JT,
   2. Capps SG.

   Intra-articular tranexamic acid in primary total knee arthroplasty: meta-analysis. J Knee Surg 2018; 31: 56–67.

   OpenUrl
4. 4.↵
   1. Zhu J,
   2. Zhu Y,
   3. Lei P,
   4. Zeng M,
   5. Su W,
   6. Hu Y.

   Efficacy and safety of tranexamic acid in total hip replacement: a PRISMA-compliant meta-analysis of 25 randomized controlled trials. Medicine (Baltimore) 2017; 96: e9552.

   OpenUrl
5. 5.↵
   1. Zufferey PJ,
   2. Lanoiselée J,
   3. Chapelle C,
   4. Borisov DB,
   5. Bien JY,
   6. Lambert P, et al.

   Intravenous tranexamic acid bolus plus infusion is not more effective than a single bolus in primary hip arthroplasty: a randomized controlled trial. Anesthesiology 2017; 127: 413–422.

   OpenUrl
6. 6.↵
   1. Grosso MJ,
   2. Trofa DP,
   3. Danoff JR,
   4. Hickernell TR,
   5. Murtaugh T,
   6. Lakra A, et al.

   Tranexamic acid increases early perioperative functional outcomes after total knee arthroplasty. Arthroplast Today 2017; 4: 74–77.

   OpenUrl
7. 7.↵
   1. Elwatidy S,
   2. Jamjoom Z,
   3. Elgamal E,
   4. Zakaria A,
   5. Turkistani A,
   6. El-Dawlatly A.

   Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study. Spine (Phila Pa 1976) 2008; 33: 2577–2580.

   OpenUrl
8. 8.↵
   1. Alajmi T,
   2. Saeed H,
   3. Alfaryan K,
   4. Alakeel A,
   5. Alfaryan T.

   Efficacy of tranexamic acid in reducing blood loss and blood transfusion in idiopathic scoliosis: a systematic review and meta-analysis. J Spine Surg 2017; 3: 531–540.

   OpenUrl
9. 9.↵
   1. Ftaita S,
   2. Pagnano M,
   3. Thienpont E.

   The perioperative management of partial knee arthroplasty: anesthesia, pain management, and blood loss. Partial Knee Arthroplasty 2019; 11–18.
10. 10.↵
    1. Franchini M,
    2. Mengoli C,
    3. Marietta M,
    4. Marano G,
    5. Vaglio S,
    6. Pupella S, et al.

    Safety of intravenous tranexamic acid in patients undergoing majororthopaedic surgery: a meta-analysis of randomised controlled trials. Blood Transfus 2018; 16: 36–43.

    OpenUrl
11. 11.↵
    1. Luo ZY,
    2. Wang HY,
    3. Wang D,
    4. Zhou K,
    5. Pei FX,
    6. Zhou ZK.

    Oral vs intravenous vs topical tranexamic acid in primary hip arthroplasty: a prospective, randomized, double-blind, controlled study. J Arthroplasty 2018; 33: 786–793.

    OpenUrl
12. 12.↵
    1. Clavé A,
    2. Gérard R,
    3. Lacroix J,
    4. Baynat C,
    5. Danguy des Déserts M,
    6. Gatineau F, et al.

    A randomized, double-blind, placebo-controlled trial on the efficacy of tranexamic acid combined with rivaroxaban thromboprophylaxis in reducing blood loss after primary cementless total hip arthroplasty. Bone Joint J 2019; 101-B: 207–212.

    OpenUrl
13. 13.↵
    1. Sandri A,
    2. Mimor BF,
    3. Ditta A,
    4. Finocchio E,
    5. Danzi V,
    6. Piccoli P, et al.

    Perioperative intravenous tranexamic acid reduces blood transfusion in primary cementless total hip arthroplasty. Acta Biomed 2019; 90: 81–86.

    OpenUrl
14. 14.↵
    1. Xie J,
    2. Hu Q,
    3. Huang Q,
    4. Chen G,
    5. Zhou Z,
    6. Pei F.

    Efficacy and safety of tranexamic acid in geriatric hip fracture with hemiarthroplasty: a retrospective cohort study. BMC Musculoskelet Disord 2019; 20: 304.

    OpenUrl